Pharmaceuticals

Global Post-Marketing Pharmacovigilance And Medical Information Market 2025–2029: Competitive Insights and Opportunities

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Post-Marketing Pharmacovigilance And Medical Information Industry By The Forecast Year 2029?

The post-marketing pharmacovigilance and medical information market has experienced significant expansion recently. It is forecast to grow from $6.16 billion in 2024 to $6.90 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.9%. This historical growth can be linked to factors such as the increasing integration of AI in pharmacovigilance processes, a heightened demand for outsourced drug safety services, the rising complexity of biopharmaceutical products, an increasing focus on patient-reported outcomes, and greater collaboration between regulatory agencies and the industry.

The post-marketing pharmacovigilance and medical information market size is projected for substantial expansion in the coming years. This market is anticipated to reach $10.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This projected growth is driven by several factors, including enhanced drug safety analytics tools, a greater uptake of cloud-based pharmacovigilance solutions, an increase in the introduction of new therapeutic products, a heightened focus on proactive risk management approaches, and expanding pharmacovigilance demands in developing regions. Key trends anticipated during this period encompass progress in automated adverse event detection, the creation of integrated pharmacovigilance platforms, breakthroughs in real-time safety data surveillance, improvements in patient engagement instruments for reporting safety information, and the evolution of predictive analytics for evaluating drug risks.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Are The Main Drivers Boosting The Post-Marketing Pharmacovigilance And Medical Information Industry’s Expansion?

The expanding occurrence of adverse drug reactions is projected to fuel the growth of the post-marketing pharmacovigilance and medical information market moving forward. These reactions refer to harmful or unintended effects experienced when a medication is taken at its recommended dosage for prevention, diagnosis, or treatment. The prevalence of adverse drug reactions is increasing due to the aging population’s growing need for treatment of multiple chronic conditions. This often results in the concurrent use of several medications, heightening the probability of adverse drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information are essential in managing adverse drug reactions by detecting, tracking, and sharing details about potential side effects after a drug is launched, thereby helping to maintain its safety and effectiveness. A notable example is from January 2023, when Navikenz, a US-based artificial intelligence-focused IT services company, reported that in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, a figure exceeding the combined fatalities from stroke and diabetes. Furthermore, roughly 2.7 million cases each year result in over 100,000 hospitalizations and more than 15,000 deaths. This rising incidence of adverse drug reactions is thus driving the growth of the post-marketing pharmacovigilance and medical information market.

How Is The Post-Marketing Pharmacovigilance And Medical Information Market Segmented?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Product: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Key Trends Are Expected To Influence The Post-Marketing Pharmacovigilance And Medical Information Market In The Coming Years?

Key players within the post-marketing pharmacovigilance and medical information market are primarily focused on developing advanced solutions, such as AI-powered pharmacovigilance workflows, to improve the accuracy of adverse event detection and enable continuous safety monitoring for enhanced patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby accelerating the identification of adverse events and boosting regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a centralized Summary of Product Characteristics (SmPC) management system tailored for life science companies and research organizations. This innovative platform unifies essential drug safety information into one easily accessible location, automates the surveillance of literature and regulatory submissions, strengthens team collaboration, and streamlines compliance processes through its sophisticated AI functionalities. As a result, pharmacovigilance teams can operate more effectively and preemptively, ensuring both patient safety and adherence to regulatory mandates.

Which Global Market Leaders Are Shaping The Future Of The Post-Marketing Pharmacovigilance And Medical Information Sector?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Post-Marketing Pharmacovigilance And Medical Information Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2025, By The Business Research Company

Drain Cleaning Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info